Related Experiment Videos

Differences in the length of initial hospital stay in very preterm infants

Emmi Korvenranta1, Miika Linna, Unto Häkkinen

  • 1Department of Pediatrics, Turku University Hospital, Turku, Finland. emmi.korvenranta@utu.fi

Acta Paediatrica (Oslo, Norway : 1992)
|September 14, 2007
PubMed

Insights

Regional differences significantly impact the length of hospital stay for very preterm infants. Shorter initial stays were linked to lower rehospitalization rates within the first year.

Area of Science:

  • Neonatal care
  • Pediatric health outcomes
  • Public health policy

Background:

  • Very preterm infants (<32 weeks gestation or <1501g birthweight) have prolonged hospital stays.
  • Factors influencing initial hospital stay and rehospitalization rates require further investigation.

Purpose of the Study:

  • To examine maternal, infant, and hospital district factors affecting initial hospital stay duration in very preterm infants.
  • To analyze the rehospitalization rate within one year post-discharge for this population.

Main Methods:

  • A Finnish register study analyzed data from 2148 very preterm infants born between 2000-2003.
  • Generalized linear models (GLM) were used to identify factors influencing length of stay (LOS).

Main Results:

  • Significant regional variations in LOS were observed, with differences up to 10.5 days between hospital districts (p < 0.0001).
  • The rehospitalization rate within the first year was 47.2%.
  • Absence of rehospitalization correlated with a 4.1-day shorter initial LOS (p < 0.0001).

Conclusions:

  • Substantial regional disparities in LOS for very preterm infants exist, even with similar case mixes.
  • These variations likely stem from differing treatment practices and discharge criteria across regions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...